A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers
Resource Type
Journal
Authors
Banerji, Udai ; Dean, Emma J. ; Alejandro Perez-Fidalgo, J. ; Batist, Gerald ; Bedard, Philippe L. ; You, Benoit ; Westin, Shannon N. ; Kabos, Peter ; Garrett, Michelle D. ; Tall, Mathew ; Ambrose, Helen ; Barrett, J. Carl ; Carr, T. Hedley ; Cheung, S. Y. Amy ; Corcoran, Claire ; Cullberg, Marie ; Davies, Barry R. ; de Bruin, Elza C. ; Elvin, Paul ; Foxley, Andrew ; Lawrence, Peter ; Lindemann, Justin P. O. ; Maudsley, Rhiannon ; Pass, Martin ; Rowlands, Vicky ; Rugman, Paul ; Schiavon, Gaia ; Yates, James ; Schellens, Jan H. M.
Source
CLINICAL CANCER RESEARCH ; MAY 1 2018, 24 9, p2050-p2059, 10p.
Subject
Language
English
ISSN
15573265